Simplex Trading
BLCM

Simplex Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Simplex Trading’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,103
Closed -$53.6K – 8087
2019
Q2 		$69K Buy
4,103
+490
+14% +$13.3K ﹤0.01% 4563
2019
Q1 		$121K Buy
3,613
+2,982
+473% +$99.7K ﹤0.01% 4143
2018
Q4 		$18K Buy
+631
New +$28K ﹤0.01% 5441
2018
Q3 		– Sell
-667
Closed -$45.2K – 8279
2018
Q2 		$49K Sell
667
-108
-14% -$8.42K ﹤0.01% 5082
2018
Q1 		$50K Buy
775
+293
+61% +$22.1K ﹤0.01% 2451
2017
Q4 		$40K Sell
482
-776
-62% -$76.1K ﹤0.01% 2663
2017
Q3 		$145K Buy
1,258
+838
+200% +$88.2K 0.01% 1428
2017
Q2 		$49K Sell
420
-373
-47% -$46.3K ﹤0.01% 2420
2017
Q1 		$97K Sell
793
-28
-3% -$3.67K ﹤0.01% 1784
2016
Q4 		$111K Sell
821
-900
-52% -$160K 0.01% 1452
2016
Q3 		$342K Buy
1,721
+1,434
+500% +$247K 0.02% 700
2016
Q2 		$37K Buy
287
+214
+293% +$23.8K ﹤0.01% 2348
2016
Q1 		$6K Sell
73
-272
-79% -$29.6K ﹤0.01% 3984
2015
Q4 		$69K Buy
+345
New +$61.7K 0.01% 1655

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's BLCM Position: Q3 2019 in Review

Simplex Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 4,103 shares — an estimated $53.6K sold.

Simplex Trading first reported a position in BLCM in Q4 2015 and held it in 14 quarters. The position peaked at $342K in Q3 2016. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Simplex Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 4,103 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $53.6K.
  • Simplex Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Simplex Trading's Bellicum Pharmaceuticals, Inc. position peaked at $342K in Q3 2016.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.